MyHealth@EU Core
1.0.0 - trial-use 150

MyHealth@EU Core - Local Development build (v1.0.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

## ValueSet: eHDSI Vaccine With Exceptions

Official URL: http://fhir.ehdsi.eu/core/ValueSet/eHDSIVaccineWithExceptions | Version: 1.0.0
Standards status: Trial-use | Maturity Level: 2 | Computable Name: EHDSIVaccineWithExceptions
Copyright/Legal: The Value Set incorporates SNOMED CT®, used by permission of the International Health Terminology Standards Development Organisation, trading as SNOMED International. SNOMED CT was originally created by the College of American Pathologists. SNOMED CT is a registered trademark of the International Health Terminology Standards Development Organisation, all rights reserved. For further information on the use of SNOMED CT, including translations, implementers of MyHealth@EU should review usage terms or directly contact SNOMED International: info@snomed.org.

The Value Set is used to identify the patient's vaccinations. It also contains exceptional values.

References

- Immunization (Core)

### Logical Definition (CLD)

This value set includes codes based on the following rules:

- Import all the codes that are contained in eHDSI Vaccine
- Import all the codes that are contained in eHDSI Exceptional Value

### Expansion

Expansion from tx.fhir.org based on:

- SNOMED CT International edition 01-Feb 2025
- codesystem NullFlavor v3.0.0 (CodeSystem)
- codesystem WHO ATC version 2025
- valueset eHDSI Exceptional Value v9.1.0 (ValueSet)
- valueset eHDSI Vaccine v9.1.0 (ValueSet)

This value set contains 223 concepts

System | Code | Display (en) | Inactive | Definition | status | JSON | XML
`http://snomed.info/sct` | 1001000221103 | Inactivated cholera vaccine in oral dose form |  |  |  |  |
`http://snomed.info/sct` | 1011000221100 | Live attenuated Vibrio cholerae antigen only vaccine product in oral dose form |  |  |  |  |
`http://snomed.info/sct` | 1031000221108 | Human poliovirus antigen-containing vaccine product |  |  |  |  |
`http://snomed.info/sct` | 1051000221104 | Live attenuated poliovirus serotypes 1 and 3 vaccine in oral dose form |  |  |  |  |
`http://snomed.info/sct` | 1052328007 | Pneumococcal 4, 6B, 9V, 14, 18C, 19F, and 23F conjugate vaccine |  |  |  |  |
`http://snomed.info/sct` | 1081000221109 | Live attenuated rotavirus vaccine |  |  |  |  |
`http://snomed.info/sct` | 1101000221104 | Clostridium tetani toxoid antigen-containing vaccine product |  |  |  |  |
`http://snomed.info/sct` | 1119254000 | Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F capsular polysaccharide antigens only vaccine product | inactive |  | inactive |  |
`http://snomed.info/sct` | 1119305005 | 2019 novel coronavirus antigen vaccine |  |  |  |  |
`http://snomed.info/sct` | 1119349007 | Severe acute respiratory syndrome coronavirus 2 mRNA only vaccine product |  |  |  |  |
`http://snomed.info/sct` | 1121000221106 | Live attenuated Yellow fever virus antigen only vaccine product |  |  |  |  |
`http://snomed.info/sct` | 1131000221109 | Vaccine product containing only inactivated whole Rabies lyssavirus antigen |  |  |  |  |
`http://snomed.info/sct` | 1157024006 | Inactivated whole SARS-CoV-2 antigen vaccine |  |  |  |  |
`http://snomed.info/sct` | 1162643001 | Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen only vaccine product |  |  |  |  |
`http://snomed.info/sct` | 1181000221105 | Influenza virus antigen only vaccine product |  |  |  |  |
`http://snomed.info/sct` | 1801000221105 | Streptococcus pneumoniae capsular polysaccharide antigen conjugated only vaccine product |  |  |  |  |
`http://snomed.info/sct` | 1861000221106 | Bacillus Calmette-Guerin vaccine |  |  |  |  |
`http://snomed.info/sct` | 1981000221108 | Meningococcus serogroup B vaccine |  |  |  |  |
`http://snomed.info/sct` | 2171000221104 | Typhoid polysaccharide vaccine in parenteral dose form |  |  |  |  |
`http://snomed.info/sct` | 2221000221107 | Live attenuated Human alphaherpesvirus 3 only vaccine product |  |  |  |  |
`http://snomed.info/sct` | 28531000087107 | COVID-19 vaccine |  |  |  |  |
`http://snomed.info/sct` | 29061000087103 | COVID-19 non-replicating viral vector vaccine |  |  |  |  |
`http://snomed.info/sct` | 37146000 | Typhus vaccine |  |  |  |  |
`http://snomed.info/sct` | 409568008 | Pentavalent botulinum toxoid vaccine |  |  |  |  |
`http://snomed.info/sct` | 428601009 | Paratyphoid vaccine |  |  |  |  |
`http://snomed.info/sct` | 601000221108 | Bordetella pertussis antigen-containing vaccine product |  |  |  |  |
`http://snomed.info/sct` | 774618008 | Whole cell Bordetella pertussis and Clostridium tetani toxoid adsorbed and Corynebacterium diphtheriae toxoid antigens only vaccine product |  |  |  |  |
`http://snomed.info/sct` | 775641005 | Clostridium tetani toxoid adsorbed and Corynebacterium diphtheriae toxoid antigens only vaccine product |  |  |  |  |
`http://snomed.info/sct` | 777725002 | Clostridium tetani toxoid antigen adsorbed only vaccine product |  |  |  |  |
`http://snomed.info/sct` | 836368004 | Bacteria antigen-containing vaccine product |  |  |  |  |
`http://snomed.info/sct` | 836369007 | Virus antigen-containing vaccine product |  |  |  |  |
`http://snomed.info/sct` | 836374004 | Hepatitis B virus antigen-containing vaccine product |  |  |  |  |
`http://snomed.info/sct` | 836375003 | Hepatitis A virus antigen-containing vaccine product |  |  |  |  |
`http://snomed.info/sct` | 836377006 | Influenza virus antigen-containing vaccine product |  |  |  |  |
`http://snomed.info/sct` | 836378001 | Japanese encephalitis virus antigen-containing vaccine product |  |  |  |  |
`http://snomed.info/sct` | 836379009 | Human papillomavirus antigen-containing vaccine product |  |  |  |  |
`http://snomed.info/sct` | 836380007 | Haemophilus influenzae type b antigen-containing vaccine product |  |  |  |  |
`http://snomed.info/sct` | 836381006 | Corynebacterium diphtheriae antigen-containing vaccine product |  |  |  |  |
`http://snomed.info/sct` | 836382004 | Measles morbillivirus antigen-containing vaccine product |  |  |  |  |
`http://snomed.info/sct` | 836383009 | Vibrio cholerae antigen-containing vaccine product |  |  |  |  |
`http://snomed.info/sct` | 836384003 | Bacillus anthracis antigen-containing vaccine product |  |  |  |  |
`http://snomed.info/sct` | 836385002 | Yellow fever virus antigen-containing vaccine product |  |  |  |  |
`http://snomed.info/sct` | 836387005 | Rotavirus antigen-containing vaccine product |  |  |  |  |
`http://snomed.info/sct` | 836388000 | Rubella virus antigen-containing vaccine product |  |  |  |  |
`http://snomed.info/sct` | 836389008 | Vaccinia virus antigen-containing vaccine product |  |  |  |  |
`http://snomed.info/sct` | 836390004 | Salmonella enterica subspecies enterica serovar Typhi antigen-containing vaccine product |  |  |  |  |
`http://snomed.info/sct` | 836393002 | Rabies lyssavirus antigen-containing vaccine product |  |  |  |  |
`http://snomed.info/sct` | 836397001 | Coxiella burnetii antigen-containing vaccine product |  |  |  |  |
`http://snomed.info/sct` | 836398006 | Streptococcus pneumoniae antigen-containing vaccine product |  |  |  |  |
`http://snomed.info/sct` | 836401009 | Neisseria meningitidis antigen-containing vaccine product |  |  |  |  |
`http://snomed.info/sct` | 836402002 | Bacillus Calmette-Guerin antigen-containing vaccine product |  |  |  |  |
`http://snomed.info/sct` | 836403007 | Tick-borne encephalitis virus antigen-containing vaccine product |  |  |  |  |
`http://snomed.info/sct` | 836495005 | Human alphaherpesvirus 3 antigen-containing vaccine product |  |  |  |  |
`http://snomed.info/sct` | 836498007 | Mumps orthorubulavirus antigen-containing vaccine product |  |  |  |  |
`http://snomed.info/sct` | 836500008 | Haemophilus influenzae type b and Neisseria meningitidis serogroup C antigens only vaccine product |  |  |  |  |
`http://snomed.info/sct` | 840549009 | Yersinia pestis antigen-containing vaccine product |  |  |  |  |
`http://snomed.info/sct` | 840563003 | Dengue virus antigen-containing vaccine product |  |  |  |  |
`http://snomed.info/sct` | 840599008 | Borrelia burgdorferi antigen-containing vaccine product |  |  |  |  |
`http://snomed.info/sct` | 863911006 | Clostridium tetani antigen-containing vaccine product |  |  |  |  |
`http://snomed.info/sct` | 871726005 | Rabies vaccine |  |  |  |  |
`http://snomed.info/sct` | 871737006 | Mumps orthorubulavirus antigen only vaccine product |  |  |  |  |
`http://snomed.info/sct` | 871738001 | Live attenuated mumps vaccine |  |  |  |  |
`http://snomed.info/sct` | 871739009 | Human poliovirus antigen only vaccine product |  |  |  |  |
`http://snomed.info/sct` | 871740006 | Inactivated whole Human poliovirus antigen only vaccine product |  |  |  |  |
`http://snomed.info/sct` | 871742003 | Tetanus vaccine |  |  |  |  |
`http://snomed.info/sct` | 871751006 | Hepatitis A virus antigen only vaccine product |  |  |  |  |
`http://snomed.info/sct` | 871759008 | Acellular Bordetella pertussis only vaccine product |  |  |  |  |
`http://snomed.info/sct` | 871764007 | Haemophilus influenzae type b vaccine |  |  |  |  |
`http://snomed.info/sct` | 871765008 | Measles vaccine |  |  |  |  |
`http://snomed.info/sct` | 871768005 | Influenza virus antigen only vaccine product in nasal dose form |  |  |  |  |
`http://snomed.info/sct` | 871772009 | Influenza H1N1 vaccine |  |  |  |  |
`http://snomed.info/sct` | 871803007 | Hepatitis A and Hepatitis B virus antigens only vaccine product |  |  |  |  |
`http://snomed.info/sct` | 871804001 | Hepatitis A virus and Salmonella enterica subspecies enterica serovar Typhi antigens only vaccine product |  |  |  |  |
`http://snomed.info/sct` | 871806004 | Haemophilus influenzae type b and Hepatitis B virus antigens only vaccine product |  |  |  |  |
`http://snomed.info/sct` | 871826000 | Diphtheria and tetanus vaccine |  |  |  |  |
`http://snomed.info/sct` | 871831003 | Measles and mumps and rubella vaccine |  |  |  |  |
`http://snomed.info/sct` | 871837004 | Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens only vaccine product |  |  |  |  |
`http://snomed.info/sct` | 871839001 | Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b antigens only vaccine product |  |  |  |  |
`http://snomed.info/sct` | 871866001 | Neisseria meningitidis serogroup C only vaccine product |  |  |  |  |
`http://snomed.info/sct` | 871871008 | Meningitis A and C vaccine |  |  |  |  |
`http://snomed.info/sct` | 871873006 | Meningitis A, C, W135 and Y vaccine |  |  |  |  |
`http://snomed.info/sct` | 871875004 | Diphtheria and pertussis and tetanus vaccine |  |  |  |  |
`http://snomed.info/sct` | 871876003 | Diphtheria and acellular pertussis and tetanus vaccine |  |  |  |  |
`http://snomed.info/sct` | 871878002 | Diphtheria and pertussis and poliomyelitis and tetanus vaccine |  |  |  |  |
`http://snomed.info/sct` | 871887006 | Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens only vaccine product |  |  |  |  |
`http://snomed.info/sct` | 871889009 | Diphtheria and hepatitis B and inactivated poliomyelitis and acellular pertussis vaccine |  |  |  |  |
`http://snomed.info/sct` | 871895005 | Diphtheria and Haemophilus influenzae type b and hepatitis B and pertussis and poliomyelitis and tetanus |  |  |  |  |
`http://snomed.info/sct` | 871908002 | Human alphaherpesvirus 3 and Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens only vaccine product |  |  |  |  |
`http://snomed.info/sct` | 871918007 | Rickettsia antigen-containing vaccine product |  |  |  |  |
`http://snomed.info/sct` | 871921009 | Staphylococcus toxoid vaccine |  |  |  |  |
`http://snomed.info/sct` | 921000221108 | Neisseria meningitidis antigen only vaccine product |  |  |  |  |
`http://snomed.info/sct` | 971000221109 | Live attenuated Salmonella enterica subspecies enterica serovar Typhi antigen only vaccine product in oral dose form |  |  |  |  |
`http://snomed.info/sct` | 981000221107 | Pneumococcal vaccine |  |  |  |  |
`http://www.whocc.no/atc` | J07AC | Anthrax vaccines |  |  |  |  |
`http://www.whocc.no/atc` | J07AC01 | anthrax antigen |  |  |  |  |
`http://www.whocc.no/atc` | J07AD | Brucellosis vaccines |  |  |  |  |
`http://www.whocc.no/atc` | J07AD01 | brucella antigen |  |  |  |  |
`http://www.whocc.no/atc` | J07AE | Cholera vaccines |  |  |  |  |
`http://www.whocc.no/atc` | J07AE01 | cholera, inactivated, whole cell |  |  |  |  |
`http://www.whocc.no/atc` | J07AE02 | cholera, live attenuated |  |  |  |  |
`http://www.whocc.no/atc` | J07AE51 | cholera, combinations with typhoid vaccine, inactivated, whole cell |  |  |  |  |
`http://www.whocc.no/atc` | J07AF | Diphtheria vaccines |  |  |  |  |
`http://www.whocc.no/atc` | J07AF01 | diphtheria toxoid |  |  |  |  |
`http://www.whocc.no/atc` | J07AG | Haemophilus influenzae B vaccines |  |  |  |  |
`http://www.whocc.no/atc` | J07AG01 | haemophilus influenzae B, purified antigen conjugated |  |  |  |  |
`http://www.whocc.no/atc` | J07AG51 | haemophilus influenzae B, combinations with toxoids |  |  |  |  |
`http://www.whocc.no/atc` | J07AG52 | haemophilus influenzae B, combinations with pertussis and toxoids |  |  |  |  |
`http://www.whocc.no/atc` | J07AG53 | haemophilus influenzae B, combinations with meningococcus C, conjugated |  |  |  |  |
`http://www.whocc.no/atc` | J07AG54 | haemophilus influenza B, combinations with meningococcus C,Y, conjugated |  |  |  |  |
`http://www.whocc.no/atc` | J07AH | Meningococcal vaccines |  |  |  |  |
`http://www.whocc.no/atc` | J07AH01 | meningococcus A, purified polysaccharides antigen |  |  |  |  |
`http://www.whocc.no/atc` | J07AH02 | other meningococcal monovalent purified polysaccharides antigen |  |  |  |  |
`http://www.whocc.no/atc` | J07AH03 | meningococcus A,C, bivalent purified polysaccharides antigen |  |  |  |  |
`http://www.whocc.no/atc` | J07AH04 | meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen |  |  |  |  |
`http://www.whocc.no/atc` | J07AH05 | other meningococcal polyvalent purified polysaccharides antigen |  |  |  |  |
`http://www.whocc.no/atc` | J07AH06 | meningococcus B, outer membrane vesicle vaccine |  |  |  |  |
`http://www.whocc.no/atc` | J07AH07 | meningococcus C, purified polysaccharides antigen conjugated |  |  |  |  |
`http://www.whocc.no/atc` | J07AH08 | meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated |  |  |  |  |
`http://www.whocc.no/atc` | J07AH09 | meningococcus B, multicomponent vaccine |  |  |  |  |
`http://www.whocc.no/atc` | J07AH10 | meningococcus A, purified polysaccharides antigen conjugated |  |  |  |  |
`http://www.whocc.no/atc` | J07AH11 | meningococcus A,B,C,Y,W-135, pentavalent purified polysaccharides antigen conjugated and factor H binding protein |  |  |  |  |
`http://www.whocc.no/atc` | J07AJ | Pertussis vaccines |  |  |  |  |
`http://www.whocc.no/atc` | J07AJ01 | pertussis, inactivated, whole cell |  |  |  |  |
`http://www.whocc.no/atc` | J07AJ02 | pertussis, purified antigen |  |  |  |  |
`http://www.whocc.no/atc` | J07AJ51 | pertussis, inactivated, whole cell, combinations with toxoids |  |  |  |  |
`http://www.whocc.no/atc` | J07AJ52 | pertussis, purified antigen, combinations with toxoids |  |  |  |  |
`http://www.whocc.no/atc` | J07AK | Plague vaccines |  |  |  |  |
`http://www.whocc.no/atc` | J07AK01 | plague, inactivated, whole cell |  |  |  |  |
`http://www.whocc.no/atc` | J07AL | Pneumococcal vaccines |  |  |  |  |
`http://www.whocc.no/atc` | J07AL01 | pneumococcus, purified polysaccharides antigen |  |  |  |  |
`http://www.whocc.no/atc` | J07AL02 | pneumococcus, purified polysaccharides antigen conjugated |  |  |  |  |
`http://www.whocc.no/atc` | J07AL52 | pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated |  |  |  |  |
`http://www.whocc.no/atc` | J07AM | Tetanus vaccines |  |  |  |  |
`http://www.whocc.no/atc` | J07AM01 | tetanus toxoid |  |  |  |  |
`http://www.whocc.no/atc` | J07AM51 | tetanus toxoid, combinations with diphtheria toxoid |  |  |  |  |
`http://www.whocc.no/atc` | J07AM52 | tetanus toxoid, combinations with tetanus immunoglobulin |  |  |  |  |
`http://www.whocc.no/atc` | J07AN | Tuberculosis vaccines |  |  |  |  |
`http://www.whocc.no/atc` | J07AN01 | tuberculosis, live attenuated |  |  |  |  |
`http://www.whocc.no/atc` | J07AP | Typhoid vaccines |  |  |  |  |
`http://www.whocc.no/atc` | J07AP01 | typhoid, oral, live attenuated |  |  |  |  |
`http://www.whocc.no/atc` | J07AP02 | typhoid, inactivated, whole cell |  |  |  |  |
`http://www.whocc.no/atc` | J07AP03 | typhoid, purified polysaccharide antigen |  |  |  |  |
`http://www.whocc.no/atc` | J07AP10 | typhoid, combinations with paratyphi types |  |  |  |  |
`http://www.whocc.no/atc` | J07AR | Typhus (exanthematicus) vaccines |  |  |  |  |
`http://www.whocc.no/atc` | J07AR01 | typhus exanthematicus, inactivated, whole cell |  |  |  |  |
`http://www.whocc.no/atc` | J07AX | Other bacterial vaccines |  |  |  |  |
`http://www.whocc.no/atc` | J07AX01 | leptospira vaccines |  |  |  |  |
`http://www.whocc.no/atc` | J07BA | Encephalitis vaccines |  |  |  |  |
`http://www.whocc.no/atc` | J07BA01 | encephalitis, tick borne, inactivated, whole virus |  |  |  |  |
`http://www.whocc.no/atc` | J07BA02 | encephalitis, Japanese, inactivated, whole virus |  |  |  |  |
`http://www.whocc.no/atc` | J07BA03 | encephalitis, Japanese, live attenuated |  |  |  |  |
`http://www.whocc.no/atc` | J07BB | Influenza vaccines |  |  |  |  |
`http://www.whocc.no/atc` | J07BB01 | influenza, inactivated, whole virus |  |  |  |  |
`http://www.whocc.no/atc` | J07BB02 | influenza, inactivated, split virus or surface antigen |  |  |  |  |
`http://www.whocc.no/atc` | J07BB03 | influenza, live attenuated |  |  |  |  |
`http://www.whocc.no/atc` | J07BB04 | influenza, virus like particles |  |  |  |  |
`http://www.whocc.no/atc` | J07BB05 | influenza, RNA-based vaccine |  |  |  |  |
`http://www.whocc.no/atc` | J07BC | Hepatitis vaccines |  |  |  |  |
`http://www.whocc.no/atc` | J07BC01 | hepatitis B, purified antigen |  |  |  |  |
`http://www.whocc.no/atc` | J07BC02 | hepatitis A, inactivated, whole virus |  |  |  |  |
`http://www.whocc.no/atc` | J07BC20 | combinations |  |  |  |  |
`http://www.whocc.no/atc` | J07BD | Measles vaccines |  |  |  |  |
`http://www.whocc.no/atc` | J07BD01 | measles, live attenuated |  |  |  |  |
`http://www.whocc.no/atc` | J07BD51 | measles, combinations with mumps, live attenuated |  |  |  |  |
`http://www.whocc.no/atc` | J07BD52 | measles, combinations with mumps and rubella, live attenuated |  |  |  |  |
`http://www.whocc.no/atc` | J07BD53 | measles, combinations with rubella, live attenuated |  |  |  |  |
`http://www.whocc.no/atc` | J07BD54 | measles, combinations with mumps, rubella and varicella, live attenuated |  |  |  |  |
`http://www.whocc.no/atc` | J07BE | Mumps vaccines |  |  |  |  |
`http://www.whocc.no/atc` | J07BE01 | mumps, live attenuated |  |  |  |  |
`http://www.whocc.no/atc` | J07BF | Poliomyelitis vaccines |  |  |  |  |
`http://www.whocc.no/atc` | J07BF01 | poliomyelitis oral, monovalent, live attenuated |  |  |  |  |
`http://www.whocc.no/atc` | J07BF02 | poliomyelitis oral, trivalent, live attenuated |  |  |  |  |
`http://www.whocc.no/atc` | J07BF03 | poliomyelitis, trivalent, inactivated, whole virus |  |  |  |  |
`http://www.whocc.no/atc` | J07BF04 | poliomyelitis oral, bivalent, live attenuated |  |  |  |  |
`http://www.whocc.no/atc` | J07BG | Rabies vaccines |  |  |  |  |
`http://www.whocc.no/atc` | J07BG01 | rabies, inactivated, whole virus |  |  |  |  |
`http://www.whocc.no/atc` | J07BH | Rota virus diarrhea vaccines |  |  |  |  |
`http://www.whocc.no/atc` | J07BH01 | rota virus, live attenuated |  |  |  |  |
`http://www.whocc.no/atc` | J07BH02 | rota virus, pentavalent, live, reassorted |  |  |  |  |
`http://www.whocc.no/atc` | J07BJ | Rubella vaccines |  |  |  |  |
`http://www.whocc.no/atc` | J07BJ01 | rubella, live attenuated |  |  |  |  |
`http://www.whocc.no/atc` | J07BJ51 | rubella, combinations with mumps, live attenuated |  |  |  |  |
`http://www.whocc.no/atc` | J07BK | Varicella zoster vaccines |  |  |  |  |
`http://www.whocc.no/atc` | J07BK01 | varicella, live attenuated |  |  |  |  |
`http://www.whocc.no/atc` | J07BK02 | zoster, live attenuated |  |  |  |  |
`http://www.whocc.no/atc` | J07BK03 | zoster, purified antigen |  |  |  |  |
`http://www.whocc.no/atc` | J07BL | Yellow fever vaccines |  |  |  |  |
`http://www.whocc.no/atc` | J07BL01 | yellow fever, live attenuated |  |  |  |  |
`http://www.whocc.no/atc` | J07BM | Papillomavirus vaccines |  |  |  |  |
`http://www.whocc.no/atc` | J07BM01 | papillomavirus (human types 6, 11, 16, 18) |  |  |  |  |
`http://www.whocc.no/atc` | J07BM02 | papillomavirus (human types 16, 18) |  |  |  |  |
`http://www.whocc.no/atc` | J07BM03 | papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58) |  |  |  |  |
`http://www.whocc.no/atc` | J07BN | Covid-19 vaccines |  |  |  |  |
`http://www.whocc.no/atc` | J07BN01 | covid-19, RNA-based vaccine |  |  |  |  |
`http://www.whocc.no/atc` | J07BN02 | covid-19, viral vector, non-replicating |  |  |  |  |
`http://www.whocc.no/atc` | J07BN03 | covid-19, inactivated virus |  |  |  |  |
`http://www.whocc.no/atc` | J07BN04 | covid-19, protein subunit |  |  |  |  |
`http://www.whocc.no/atc` | J07BN05 | covid-19, virus-like particles |  |  |  |  |
`http://www.whocc.no/atc` | J07BX | Other viral vaccines |  |  |  |  |
`http://www.whocc.no/atc` | J07BX01 | smallpox and monkeypox vaccines |  |  |  |  |
`http://www.whocc.no/atc` | J07BX02 | ebola vaccines |  |  |  |  |
`http://www.whocc.no/atc` | J07BX04 | dengue virus vaccines |  |  |  |  |
`http://www.whocc.no/atc` | J07BX05 | respiratory syncytial virus vaccines |  |  |  |  |
`http://www.whocc.no/atc` | J07BX06 | enterovirus 71 vaccines |  |  |  |  |
`http://www.whocc.no/atc` | J07CA | Bacterial and viral vaccines, combined |  |  |  |  |
`http://www.whocc.no/atc` | J07CA01 | diphtheria-poliomyelitis-tetanus |  |  |  |  |
`http://www.whocc.no/atc` | J07CA02 | diphtheria-pertussis-poliomyelitis-tetanus |  |  |  |  |
`http://www.whocc.no/atc` | J07CA03 | diphtheria-rubella-tetanus |  |  |  |  |
`http://www.whocc.no/atc` | J07CA04 | haemophilus influenzae B and poliomyelitis |  |  |  |  |
`http://www.whocc.no/atc` | J07CA05 | diphtheria-hepatitis B-pertussis-tetanus |  |  |  |  |
`http://www.whocc.no/atc` | J07CA06 | diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus |  |  |  |  |
`http://www.whocc.no/atc` | J07CA07 | diphtheria-hepatitis B-tetanus |  |  |  |  |
`http://www.whocc.no/atc` | J07CA08 | haemophilus influenzae B and hepatitis B |  |  |  |  |
`http://www.whocc.no/atc` | J07CA09 | diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B |  |  |  |  |
`http://www.whocc.no/atc` | J07CA10 | typhoid-hepatitis A |  |  |  |  |
`http://www.whocc.no/atc` | J07CA11 | diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B |  |  |  |  |
`http://www.whocc.no/atc` | J07CA12 | diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B |  |  |  |  |
`http://www.whocc.no/atc` | J07CA13 | diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A + C |  |  |  |  |
`http://www.whocc.no/atc` | J07XA | Parasitic vaccines |  |  |  |  |
`http://www.whocc.no/atc` | J07XA01 | malaria vaccines |  |  |  |  |
`http://terminology.hl7.org/CodeSystem/v3-NullFlavor` | OTH | other |  | **Description:**The actual value is not a member of the set of permitted data values in the constrained value domain of a variable. (e.g., concept not provided by required code system). Usage Notes: This flavor and its specializations are most commonly used with the CD datatype and its flavors. However, it may apply to *any* datatype where the constraints of the type are tighter than can be conveyed. For example, a PQ that is for a true measured amount whose units are not supported in UCUM, a need to convey a REAL when the type has been constrained to INT, etc. With coded datatypes, this null flavor may only be used if the vocabulary binding has a coding strength of CNE. By definition, all local codes and original text are part of the value set if the coding strength is CWE. |  |  |
`http://terminology.hl7.org/CodeSystem/v3-NullFlavor` | UNK | unknown |  | **Description:**A proper value is applicable, but not known. Usage Notes: This means the actual value is not known. If the only thing that is unknown is how to properly express the value in the necessary constraints (value set, datatype, etc.), then the OTH or UNC flavor should be used. No properties should be included for a datatype with this property unless: Those properties themselves directly translate to a semantic of "unknown". (E.g. a local code sent as a translation that conveys 'unknown') Those properties further qualify the nature of what is unknown. (E.g. specifying a use code of "H" and a URL prefix of "tel:" to convey that it is the home phone number that is unknown.) |  |  |
`http://terminology.hl7.org/CodeSystem/v3-NullFlavor` | UNC | un-encoded |  | Description: The actual value has not yet been encoded within the approved value domain. Example: Original text or a local code has been specified but translation or encoding to the approved value set has not yet occurred due to limitations of the sending system. Original text has been captured for a PQ, but not attempt has been made to split the value and unit or to encode the unit in UCUM. Usage Notes: If it is known that it is not possible to encode the concept, OTH should be used instead. However, use of UNC does not necessarily guarantee the concept will be encodable, only that encoding has not been attempted. Data type properties such as original text and translations may be present when this null flavor is included. |  |  |

Explanation of the columns that may appear on this page:

Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System | The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code | The code (used as the code in the resource instance)
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition | An explanation of the meaning of the concept
Comments | Additional notes about how to use the code